As a visualizing agent for the dopamine transporter in the brain, DaTscan provides a concrete method to distinguish DLB from other dementia types, especially Alzheimer’s Disease. This evidence concerns the gene SLC6A3 and early-onset autosomal dominant Alzheimer disease.